Autism - PowerPoint PPT Presentation

1 / 62
About This Presentation
Title:

Autism

Description:

Traumatic Midbrain Syndrome (Holbach, 1974) Closed Head Injury (Rockswold, 1992) ... Kawasaki disease (Ichiyama, 1998) Lupus (Huang, 2002; Postiglione, 1998) ... – PowerPoint PPT presentation

Number of Views:354
Avg rating:3.0/5.0
Slides: 63
Provided by: danros3
Category:
Tags: autism

less

Transcript and Presenter's Notes

Title: Autism


1
Hyper-
and
Autism
Baric
Oxygen
Therapy
Dan Rossignol, M.D. DAN! Physician Clinical
Assistant Professor University of
Virginia Department of Family Medicine
2
Outline
  • Rise in autism prevalence
  • Effects of HBOT
  • Recent autism findings
  • Cerebral Hypoperfusion and HBOT
  • Neuroinflammation and GI Inflammation and HBOT
  • Increased excretion of porphyrins and HBOT
  • Oxidative Stress and HBOT
  • HBOT safety
  • HBOT dosing
  • HBOT case series

3
Prevalence of Autism
  • According to the U.S. Dept. Developmental
    Services, the prevalence of autism spectrum
    disorders increased 556 from 1991 to 1997.
  • Autism is now more common than childhood cancer,
    Downs syndrome, spina bifida or cystic fibrosis.
  • 1 in 80 boys have autism (boys are affected 4
    times as often as girls).
  • 1 out of 68 families will have a child with
    autism.
  • Autism is increasing by 3.8 per year worldwide.

4
(No Transcript)
5
HBOT and Autism
6
HBOT Definition
  • Hyperbaric oxygen therapy (HBOT) involves
    inhaling 100 oxygen at greater than 1 atmosphere
    absolute (ATA) in a pressurized chamber.
    (Feldmeier, Undersea and Hyperbaric Medical
    Society, 2003)

7
HBOT Approved Indications
  • Air or gas embolism
  • Carbon Monoxide Poisoning
  • Gas gangrene
  • Crush injuries and compartment syndrome
  • Decompression sickness
  • Wound healing
  • Severe anemia
  • Intracranial abscess
  • Necrotizing soft tissue infections
  • Refractory osteomyelitis
  • Skin flaps and grafts
  • Delayed radiation injury
  • Thermal burns

The use of HBOT for autism is off-label
8
Effects of HBOT
Skin Cell Growth and Wound Healing
Patel, 2005
9
Effects of HBOT
Gionis et al., 1999 Intensive Care Med 26(3)355
10
Sunami, et al. Crit Care Med 2000 28 2831-36
11
(No Transcript)
12
(No Transcript)
13
Effects of HBOT
Cerebral blood flow
Demchenko et al., 2000 Nitric Oxide 6(4)597-608
14
Effects of HBOT
Cerebral blood flow
Demchenko et al., 2005 J Cereb Blood Flow Metab
25(10)1288-300
15
Effects of HBOT
Cerebral blood flow
Demchenko et al., 2005 J Cereb Blood Flow Metab
25(10)1288-300
16
Effects of HBOT
Cerebral oxygenation
Demchenko et al., 2005 J Cereb Blood Flow Metab
25(10)1288-300
17
Effects of HBOT
Hypoxia Ischemia HBOT
Hypoxia Ischemia
Control Rat Brain
Calvert et al., 2002
18
Effects of HBOT
Distribution of Ischemic Changes
Rosenthal et al., 2003
19
Effects of HBOT
Postischemic BBB permeability
Rats 3 ATA 100 oxygen
Postischemic cerebral edema
Veltkamp et al., 2005
20
Off-label Studied Uses of HBOT
  • Cerebral Palsy (Montgomery, 1999)
  • Amyotrophic Lateral Sclerosis (Steele, 2004)
  • Complex Regional Pain Syndrome (Kiralp, 2004)
  • Fetal Alcohol Syndrome (Stoller, 2005)
  • Ischemic Brain Injury (Neubauer, 1992 Neubauer,
    1998)
  • Traumatic Midbrain Syndrome (Holbach, 1974)
  • Closed Head Injury (Rockswold, 1992)
  • Lupus (Wallace, 1996)
  • Stroke (Nighoghossian, 1995)
  • Myocardial Infarction (Shandling, 1997)

21
Recent Autism Findings
  • Autistic children compared to neurotypical
    controls have
  • Relative cerebral hypoperfusion
  • Evidence of neuroinflammation
  • Increased excretion of porphyrins
  • Increased oxidative stress

22
Autism and Cerebral Hypoperfusion
fMRI Cerebellar Blood Flow and Activation
Allen et al., 2003
23
Autism and Cerebral Hypoperfusion
Muller et al., 1999
24
Abnormal Vascular Response Cerebral Hypoperfusion
Middle Cerebral Arteries
Bruneau et al., 1992
25
Zilbovicius et al., 2000
26
Autism and Cerebral Hypoperfusion
Bitemporal hypoperfusion
Boddaert et al., 2002
27
Autism and Cerebral Hypoperfusion
Bitemporal hypoperfusion
Boddaert et al., 2002
28
Wilcox, 2002
Hypoperfusion of the prefrontal and left temporal
areas worsened and became quite profound as the
age of the autistic child increased.
29
Cerebral Hypoperfusion inAutistics Correlated
Clinically with
  • Repetitive, self-stimulatory, and unusual
    behaviors including resistance to changes in
    routine and environment (Starkstein, 2000)
  • Obsessive desire for sameness and impairments
    in communication and social interaction
    (Ohnishi, 2000)
  • Impairments in processing facial expressions and
    emotions (Critchley, 2000)
  • Trouble recognizing familiar faces (Pierce, 2004)
  • Decreased language development (Wilcox, 2002) and
    auditory processing (Boddaert, 2004)
  • Decreased IQ (Hashimoto, 2000)

Thalamus
Temporal
Temporal Amygdala
Wernicke Brodmann
30
Diseases in which inflammation causes decreased
cerebral blood flow
Inflammation Cerebral Hypoperfusion
  • Sjögrens syndrome (Lass, 2001)
  • Behçets disease (Caca 2004)
  • Viral encephalitis (Wakamoto, 2000 Nishikawa
    2000)
  • Kawasaki disease (Ichiyama, 1998)
  • Lupus (Huang, 2002 Postiglione, 1998)

31
Mathieu et al., 2002
32
Abnormal Astrocyte Vascular Control Cerebral
Hypoperfusion
Reactive Astroglia (green)
Mulligan et al., 2004
Vargas et al., 2005
33
HBOT and Cerebral Hypoperfusion
  • HBOT has been used with success clinically in
    some hypoperfusion syndromes
  • Fetal alcohol syndrome (Stoller, 2005)
  • Cerebral Palsy (Montgomery, 1999 Collet, 2001)
  • Closed head injury (Rockswold, 1992)
  • Stroke (Nighoghossian, 1995)

34
HBOT and Cerebral Hypoperfusion
Baseline
Midway
End
Golden et al., 2002
35
SPECT Scans in a 4 year old autistic child after
10 sessions of HBOT at 1.3 atm and 24 oxygen
Heuser, 2002
36
Autism and Neuroinflammation
Evidence of Neuroinflammation
Vargas et al., 2005
37
Autism and Neuroinflammation
P
G
A Normal control cerebellum
B Autistic brain with loss of Purkinje cell
layer (P) and granular cell layer (G)
Vargas et al., 2005
38
Autism and Neuroinflammation
Singh et al., 2004
39
Autism and Neuroinflammation
Vojdani et al., 2002
40
Autism and Neuroinflammation
Vojdani et al., 2004
41
HBOT and Inflammation
  • Inflammation in Autistic Children
  • Multiple studies reveal that autistic individuals
    have evidence of neuroinflammation and
    gastrointestinal inflammation
  • In several studies, HBOT has been shown to have
    potent anti-inflammatory effects (Akin, 2002
    Luongo, 1998 Sumen, 2001)

42
Saline
Diclofenac 10 mg/kg
INFLAMMATION
HBOT and Diclofenac 10 mg/kg
Diclofenac 20 mg/kg
HBOT
HBOT and Diclofenac 20 mg/kg
Sumen et al., 2001
43
HBOT and Inflammation
Weisz et al., 1997 J Clin Immuno. 17(2)154-9
44
HBOT and Inflammation
HBOT, 30 sessions at 100 oxygen and 2.0 ATA
Buchman et al., 2001
45
Takeshima et al., 1999 Am J Gastroenterol
94(11)3374-5
46
Atmospheric Pressure of Oxygen
Room Air 160 mmHg
Lung Capillaries 100 mmHg
Leaving Heart 85 mmHg
Peripheral Arterioles 70 mmHg
Organ Capillaries 50 mmHg
Cells 1-10 mmHg
Mitochondria 0.5 mmHg (0.3 of inhaled oxygen)
Mitochondria is the final site of heme production
47
Autism and Oxidative Stress
Total glutathione levels were 46 lower and
oxidized glutathione was 72 higher in autistic
children compared to typical controls.
James, 2004
48
HBOT and Oxidative Stress
Dennog, 1999
49
HBOT and Oxidative Stress
50
Antioxidants, HBOTand Oxidative Stress
  • a-lipoic acid (Alleva, 2005)
  • N-acetylcysteine (Yu, 2005 Pelaia, 1995)
  • Vitamin E (Hollis, 1992)
  • Riboflavin (Boadi, 1991)
  • Selenium (Hollis, 1992 Boadi, 1991)
  • Glutathione (Weber, 1990)
  • Melatonin (Pablos, 1997)

51
HBOT and Oxidative Stress
Hippocampus
Cerebral Cortex
Melatonin
Rats 4 ATA 100 oxygen
Hypothalamus
Cerebellum
52
HBOT and Stem Cells
In humans, HBOT at 2.0 ATA and 100 oxygen for 2
hours per treatment for 20 treatments doubled the
number of circulating stem cells
Thom et al. in press
53
Thom et al. in press
54
Thom et al. in press
55
HBOT and Stem Cells
Steindler et al., 2002
56
Summary
Cerebral Hypoperfusion
AUTISM
Neuroinflammation and GI inflammation
Excretion of Porphyrins
Oxidative Stress
Neurodegenerative Disease
57
Summary
Cerebral Hypoperfusion
Neuroinflammation and GI inflammation
Excretion of Porphyrins
Oxidative Stress
Neurodegenerative Disease
Stem Cells
HBOT
58
HBOT Safety at 1.3 ATA
  • 111 children 54 received HBOT at 1.3 atm and 40
    treatments over 2 months
  • 12 children had problems with their ears
  • No other safety issues noted

Collet et al., 2001
59
Side effects of HBOT
  • Barotrauma (2)
  • Sinus squeeze
  • Serous otitis
  • Claustrophobia
  • Reversible myopia
  • Seizures (0.01 0.03)

60
HBOT Dosing
Survival of Hippocampal neurons after 5 minutes
of ischemia
Wada et al., 2001
61
Oxygen Partial Pressures
At sea level, partial pressure air 760 mm
Air has 21 oxygen, partial pressure oxygen 160
mm
1.3 ATA 28 oxygen
1.5 ATA 100 oxygen
1.0 ATA 21 oxygen
1.3 ATA 90 oxygen
160 mm Hg Oxygen
277 mmHg Oxygen
1143 mmHg Oxygen
891 mmHg Oxygen
Arterial 100 mmHg
Arterial 177 mmHg
Arterial 1036 mmHg
Arterial 557 mmHg
Venous 39 mmHg
Venous 69 mmHg
Venous 404 mmHg
Venous 217 mmHg
62
HBOT and Autism
Write a Comment
User Comments (0)
About PowerShow.com